AndrewNicholasAntoszykMD

Ophthalmology • Charlotte, NC

Retinal Disease

Assistant Consulting Professor of Ophthalmology, Duke University School of Medicine

Join to view full profile

Dr. Antoszyk is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Antoszyk's full profile

Already have an account?

Office
6035 Fairview Rd
Charlotte, NC 28210
Phone+1 704-295-3000

Fax+1 704-838-8494

Education & Training

Duke University HospitalFellowship, Surgical Retina and Vitreous, 1987 - 1989
Duke University HospitalResidency, Ophthalmology, 1984 - 1987
Duke University HospitalInternship, Internal Medicine, 1983 - 1984
New York Medical CollegeClass of 1983

Certifications & Licensure

NC State Medical License 2024 - 2025
MD State Medical License 1989 - 1992
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Heed Award Heed-Knapp foundation
CMS Meaningful Use Stage 1 Certification Medflow EHR, Medflow, Inc., 2012-2013
Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD Start of enrollment: 2015 Jul 01
Completed
Phase 1

Publications & Presentations

PubMed

489 citations
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Jeffrey G. Gross, Adam R. Glassman, Lee M. Jampol, Seidu Inusah, Lloyd Paul Aiello
JAMA. 2015-11-24
270 citations
Secondary Analyses of the Effects of Lutein/Zeaxanthin on Age-Related Macular Degeneration Progression: AREDS2 Report No. 3
Emily Y. Chew, Traci E Clemons, John Paul SanGiovanni, Ronald P. Danis, Frederick L. Ferris
JAMA Ophthalmology. 2014-02-01
1003 citations
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
John A. Wells, Adam R. Glassman, Allison R. Ayala, Lee M. Jampol, Lloyd Paul Aiello
The New England Journal of Medicine. 2015-03-26

Journal Articles

Effect of Intravitreous Aflibercept vs Vitrectomy with Panretinal Photocoagulation on Visual Acuity in Patients with Vitreous Hemorrhage from Proliferative Diabetic Re...
Andrew N Antoszyk, Chirag D Jhaveri, Omar S Punjabi, Jennifer K Sun, JAMA

Grant Support

Effects Of Corticosteroids On Retinal NeovascularizationNational Eye Institute1987–1989

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow